The basic purpose of cell culture media (semisolid, liquid, or solid) is stimulation of growth, propagation, maintenance, and at last – storage of the plant cells, microorganisms, mammalian cells, and various other cell lines. With growing demand for cell culture technology, the cell culture media market is expected to expedite in the forecast period. Plus, the fact that incidences of cancer are rising can’t be ignored. As such, governments across the globe are encouraging investment in clinical research. This is another factor to accelerate the cell culture media market in the next decade.
At the same time, it needs to be noted that ethical issues with regards to animal-derived products in culture media are springing up. Another bitter truth is that there is dearth of skilled professionals herein. These factors could act as restraining factors for cell culture market.
Cell Culture Media goes further this way…
The global cell culture media market, by product, spans serum-containing media, serum-free media (protein expression media, stem cell media, hybridoma media, primary cell media, insect cell media, immunology media, and CHO cell culture media), protein-free media, and chemically-defined media. By application, it’s cancer research, biopharmaceuticals, regenerative medicine & tissue engineering, and stem cell technologies. By end-user, it’s biopharmaceutical companies, clinical research organizations, academic research centres, and likewise. Persistence Market Research has highlighted these details with the probable calls to action in its latest market study entitled “Cell Culture Media Market”.
How about Region-wise Analysis?
North America holds the largest market share due to the US being home to growing number of biotechnology and biopharmaceutical companies like Biogen Inc. and Celgene Corporation. Europe stands second on this count with Germany ruling the roost. Also, as per the World Cancer Research Fund, sizable population of Germany is affected by cancer every single year. This is another factor boosting the cell culture media market. The Asia-Pacific is led by China and India in terms of extensive research being conducted. Persistence Market Research has given these details with corrective measures in its latest market study entitled “Cell Culture Media Market”.
To Know More – https://www.persistencemarketresearch.com/samples/31338
From the Competitors’ Desk
Persistence Market Research has profiled the key participants in the cell culture media market as Merck KGaA, Thermo Fisher Scientific Corporation, CellGenix GmbH, Corning Incorporated, Fujifilm Holdings Corporation, General Electric Company, Lonza, and BD. It has moved further with mentioning the latest developments in this regard. For instance – Fujifilm Irvine Scientific (subsidiary of Fujifilm Holdings Corporation), in June 2017, did expand its presence all across North America by coming up with state-of-the-art research and development centre in California. Around the same time, SteMaxOne media was launched by Cell Culture Technologies for human mesenchymal stem cell lines and stem cells for expanding its product portfolio along with customer base. A noteworthy part is that the media is devoid of peptide and protein. On the inorganic expansion part, Lonza, in May 2017, went on to acquire PharmaCell B.V. It is a Europe-based cell and gene contract manufacturer.
What could be inferred?
The global cell culture media market will grow backed by extensive research between 2021 and 2031 – Persistence Market Research
